As of 2026-11-16, the Relative Valuation of BioInvent International AB (BINV.ST) is (129.31) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 2.92 SEK, the upside of BioInvent International AB based on Relative Valuation is -4536.1%.
The range of the Relative Valuation is (85.39) - (157.26) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 31.8x | 22.8x |
| Forward P/E multiples | 12.9x - 25.6x | 19.2x |
| Fair Price | (85.39) - (157.26) | (129.31) |
| Upside | -3029.3% - -5495.0% | -4536.1% |
| Date | P/E |
| 2026-11-13 | -0.48 |
| 2026-11-12 | -0.48 |
| 2026-11-11 | -0.49 |
| 2026-11-10 | -0.50 |
| 2026-11-09 | -0.48 |
| 2026-11-06 | -0.41 |
| 2026-11-05 | -0.60 |
| 2026-11-04 | -0.58 |
| 2026-11-03 | -0.62 |
| 2026-11-02 | -0.70 |
| 2026-10-30 | -0.88 |
| 2026-10-29 | -0.93 |
| 2026-10-28 | -3.37 |
| 2026-10-27 | -3.39 |
| 2026-10-26 | -3.34 |
| 2026-10-23 | -3.30 |
| 2026-10-22 | -3.34 |
| 2026-10-21 | -3.34 |
| 2026-10-20 | -3.51 |
| 2026-10-19 | -3.52 |
| 2026-10-16 | -3.81 |
| 2026-10-15 | -3.83 |
| 2026-10-14 | -3.77 |
| 2026-10-13 | -3.77 |
| 2026-10-12 | -3.76 |
| 2026-10-09 | -3.78 |
| 2026-10-08 | -3.75 |
| 2026-10-07 | -3.78 |
| 2026-10-06 | -3.75 |
| 2026-10-05 | -3.73 |
| 2026-10-02 | -3.73 |
| 2026-10-01 | -3.66 |
| 2026-09-30 | -3.74 |
| 2026-09-29 | -3.66 |
| 2026-09-28 | -3.70 |
| 2026-09-25 | -3.62 |
| 2026-09-24 | -3.39 |
| 2026-09-23 | -3.61 |
| 2026-09-22 | -3.61 |
| 2026-09-21 | -3.56 |
| 2026-09-18 | -3.64 |
| 2026-09-17 | -3.65 |
| 2026-09-16 | -3.67 |
| 2026-09-15 | -3.68 |
| 2026-09-14 | -3.64 |
| 2026-09-11 | -3.70 |
| 2026-09-10 | -3.73 |
| 2026-09-09 | -3.74 |
| 2026-09-08 | -3.86 |
| 2026-09-07 | -3.87 |